Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,106

Participants

Timeline

Start Date

November 13, 2007

Primary Completion Date

November 8, 2010

Study Completion Date

November 8, 2010

Conditions
Multiple Sclerosis
Interventions
DRUG

Laquinimod

Laquinimod 0.6 mg capsule, oral, once daily

OTHER

Placebo

oral, once daily, capsule

Trial Locations (144)

1015

Teva Investigational Site 5604, Riga

1113

Teva Investigational Site 5904, Sofia

1309

Teva Investigational Site 5903, Sofia

1606

Teva Investigational Site 5900, Sofia

Teva Investigational Site 5905, Sofia

3100

Teva Investigational Site 3302, Sankt Pölten

3526

Teva Investigational Site 5116, Miskolc

4043

Teva Investigational Site 5114, Debrecen

5800

Teva Investigational Site 5901, Pleven

9010

Teva Investigational Site 5902, Varna

9020

Teva Investigational Site 3300, Klagenfurt

9500

Teva Investigational Site 3301, Villach

10003

Teva Investigational Site 1082, New York

10713

Teva Investigational Site 3241, Berlin

11000

Teva Investigational Site 6100, Belgrade

13347

Teva Investigational Site 3238, Berlin

13385

Teva Investigational Site 3528, Marseille

14186

Teva Investigational Site 4204, Stockholm

14642

Teva Investigational Site 1079, Rochester

15706

Teva Investigational Site 3139, Santiago de Compostela

17007

Teva Investigational Site 3136, Girona

17176

Teva Investigational Site 4205, Stockholm

18288

Teva Investigational Site 4206, Stockholm

19104

Teva Investigational Site 1087, Philadelphia

20122

Teva Investigational Site 3047, Milan

20132

Teva Investigational Site 3038, Milan

Teva Investigational Site 555, Milan

20148

Teva Investigational Site 3039, Milan

20246

Teva Investigational Site 3236, Hamburg

21005

Teva Investigational Site 5801, Vinnytsia

21013

Teva Investigational Site 3042, Gallarate

22417

Teva Investigational Site 3246, Hamburg

25030

Teva Investigational Site 3525, Besançon

25198

Teva Investigational Site 3135, Lleida

26721

Teva Investigational Site 3237, Emden

27157

Teva Investigational Site 1073, Winston-Salem

28040

Teva Investigational Site 3133, Madrid

28046

Teva Investigational Site 3146, Madrid

28905

Teva Investigational Site 3142, Getafe

30120

Teva Investigational Site 3137, Murcia

30559

Teva Investigational Site 3239, Hanover

31048

Teva Investigational Site 8034, Haifa

35033

Teva Investigational Site 3529, Rennes

35340

Teva Investigational Site 8201, Izmir

36001

Teva Investigational Site 3138, Pontevedra

36312

Teva Investigational Site 3140, Beade-Vigo

40513

Teva Investigational Site 1101, Lexington

43036

Teva Investigational Site 3045, Fidenza

44791

Teva Investigational Site 3248, Bochum

45417

Teva Investigational Site 1084, Dayton

46010

Teva Investigational Site 3143, Valencia

46805

Teva Investigational Site 1081, Fort Wayne

48149

Teva Investigational Site 3251, Münster

48334

Teva Investigational Site 1096, Farmington Hills

49027

Teva Investigational Site 5803, Dnipropetrovsk

50009

Teva Investigational Site 5704, Kaunas

50314

Teva Investigational Site 1083, Des Moines

53215

Teva Investigational Site 1085, Milwaukee

54292

Teva Investigational Site 3250, Trier

55414

Teva Investigational Site 1093, Minneapolis

58100

Teva Investigational Site 3046, Grosseto

58103

Teva Investigational Site 1097, Fargo

59037

Teva Investigational Site 3524, Lille

60062

Teva Investigational Site 1102, Northbrook

63003

Teva Investigational Site 3526, Clermont-Ferrand

63104

Teva Investigational Site 1098, St Louis

64711

Teva Investigational Site 3242, Erbach im Odenwald

66160

Teva Investigational Site 1086, Kansas City

69120

Teva Investigational Site 3243, Heidelberg

69677

Teva Investigational Site 3527, Bron

73120

Teva Investigational Site 1092, Oklahoma City

76231

Teva Investigational Site 5705, Šiauliai

78231

Teva Investigational Site 1078, San Antonio

78278

Teva Investigational Site 8032, Tel Aviv

79010

Teva Investigational Site 5800, Lviv

79106

Teva Investigational Site 3249, Freiburg im Breisgau

79410

Teva Investigational Site 1075, Lubbock

80112

Teva Investigational Site 1090, Centennial

80528

Teva Investigational Site 1088, Fort Collins

85004

Teva Investigational Site 1076, Phoenix

89081

Teva Investigational Site 3244, Ulm

90146

Teva Investigational Site 3041, Palermo

95122

Teva Investigational Site 3044, Catania

95445

Teva Investigational Site 3247, Bayreuth

99089

Teva Investigational Site 3240, Erfurt

127018

Teva Investigational Site 5021, Moscow

191025

Teva Investigational Site 5026, Saint Petersburg

194044

Teva Investigational Site 5025, Saint Petersburg

194354

Teva Investigational Site 5024, Saint Petersburg

197022

Teva Investigational Site 5022, Saint Petersburg

197376

Teva Investigational Site 5023, Saint Petersburg

300736

Teva Investigational Site 5209, Timișoara

400437

Teva Investigational Site 5210, Cluj-Napoca

540136

Teva Investigational Site 5211, Târgu Mureş

603126

Teva Investigational Site 5028, Nizhny Novgorod

614990

Teva Investigational Site 5030, Perm

620102

Teva Investigational Site 5029, Yekaterinburg

630087

Teva Investigational Site 5027, Novosibirsk

650066

Teva Investigational Site 5031, Kemerovo

900123

Teva Investigational Site 5212, Constanța

3436212

Teva Investigational Site 8031, Haifa

5262160

Teva Investigational Site 8033, Ramat Gan

9112001

Teva Investigational Site 8030, Jerusalem

06520-8018

Teva Investigational Site 1094, New Haven

17033-0850

Teva Investigational Site 1100, Hershey

A-4021

Teva Investigational Site 3303, Linz

B3M 0A6

Teva Investigational Site 1132, Halifax

N6A 5A5

Teva Investigational Site 1126, London

K2G 6E2

Teva Investigational Site 1128, Ottawa

M4N 3M5

Teva Investigational Site 1134, Toronto

J4V 2J2

Teva Investigational Site 1130, Greenfield Park

H1T 2M4

Teva Investigational Site 1129, Montreal

J1H 5N4

Teva Investigational Site 1131, Sherbrooke

779 00

Teva Investigational Site 5417, Olomouc

708 52

Teva Investigational Site 5416, Ostrava - Poruba

EE-10617

Teva Investigational Site 5504, Tallinn

EE-51014

Teva Investigational Site 5505, Tartu

0112

Teva Investigational Site 8100, Tbilisi

0179

Teva Investigational Site 8101, Tbilisi

01307

Teva Investigational Site 3245, Dresden

H-1145

Teva Investigational Site 5115, Budapest

H-8200

Teva Investigational Site 5117, Veszprém

00133

Teva Investigational Site 3040, Rome

6561 KE

Teva Investigational Site 3809, Groesbeek

3430 EM

Teva Investigational Site 3810, Nieuwegein

5022 GC

Teva Investigational Site 3811, Tilburg

42-200

Teva Investigational Site 5322, Częstochowa

26-200

Teva Investigational Site 5319, Gmina Końskie

66-400

Teva Investigational Site 5320, Gorzów Wielkopolski

40-752

Teva Investigational Site 5316, Katowice

25-736

Teva Investigational Site 5318, Kielce

31-826

Teva Investigational Site 5317, Krakow

90-153

Teva Investigational Site 5315, Lodz

04-749

Teva Investigational Site 5325, Warsaw

011461

Teva Investigational Site 5208, Bucharest

18 000

Teva Investigational Site 6102, Niš

08035

Teva Investigational Site 3132, Barcelona

08036

Teva Investigational Site 3134, Barcelona

08041

Teva Investigational Site 3144, Barcelona

03110

Teva Investigational Site 5802, Kyiv

03115

Teva Investigational Site 5804, Kyiv

L9 7LJ

Teva Investigational Site 3425, Liverpool

E1 2AT

Teva Investigational Site 3424, London

S10 2JF

Teva Investigational Site 3422, Sheffield

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00509145 - Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) | Biotech Hunter | Biotech Hunter